Further data from preclinical and translational studies also suggest that mTOR inhibition might suppress tumor growth by modulating hypoxia signaling and autophagy through hypoxia-inducible factor 1-alpha (HIF-1α), underscoring a broader biological rationale for its use [8]. This evidence concerns the gene HIF1A and neoplasm.